Wednesday, September 29, 2021

September 29, 2021 at 08:42PM CBER Advanced Technologies Program

In regulating the pharmaceutical manufacturing sector, FDA realizes the need for a maximally efficient, agile, flexible pharmaceutical manufacturing sector that reliably produces high quality biologics.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2NhBaOc

No comments:

Post a Comment